Geratherm Medical AG (XTER:GME) Interest Expense : €-0.18 Mil (TTM As of Jun. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Geratherm Medical AG Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Geratherm Medical AG's interest expense for the three months ended in Jun. 2023 was € 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2023 was €-0.18 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Geratherm Medical AG's Operating Income for the three months ended in Jun. 2023 was € 0.00 Mil. Geratherm Medical AG's Interest Expense for the three months ended in Jun. 2023 was € 0.00 Mil. GuruFocus does not calculate Geratherm Medical AG's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Geratherm Medical AG Interest Expense Historical Data

The historical data trend for Geratherm Medical AG's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Geratherm Medical AG Interest Expense Chart

Geratherm Medical AG Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Interest Expense

Get a 7-Day Free Trial

-0.49

-0.23

-0.27

-0.14

-0.18

Geratherm Medical AG Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23
Interest Expense	Get a 7-Day Free Trial															-0.07	-0.03	-0.04	-0.03	-

Geratherm Medical AG Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.18 Mil.

Geratherm Medical AG (XTER:GME) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Geratherm Medical AG's Interest Expense for the three months ended in Jun. 2023 was €0.00 Mil. Its Operating Income for the three months ended in Jun. 2023 was €0.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Jun. 2023 was €8.15 Mil.

Geratherm Medical AG's Interest Coverage for the quarter that ended in Jun. 2023 is calculated as

GuruFocus does not calculate Geratherm Medical AG's interest coverage with the available data.

The higher the ratio, the stronger the company's financial strength is.

Geratherm Medical AG (XTER:GME) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Geratherm Medical AG (XTER:GME) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

GME:Germany

Address

Fahrenheitstrasse 1, Geratal, DEU, 99331

Website

https://www.geratherm.com

Geratherm Medical AG is a Germany-based medical technology company. The firm operates through four segments: Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke and Respiratory. Healthcare Diagnostic segment which generates majority revenue provides analog and digital products for measuring body temperature, blood pressure monitors and other products for measuring temperature, as well as related accessories. Medical Warming Systems offers solutions for temperature management at all stages in the pre-clinical and clinical care of the patients, such as rescue situations and operations. Cardio/Stroke segment comprises products for preventing strokes. The Respiratory segment focuses on the development and production of products for pulmonary functional diagnostics.

Executives